Analystreport

Karyopharm Therapeutics Inc (NASDAQ: KPTI) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Karyopharm Therapeutics Inc.  (KPTI) 
Last karyopharm therapeutics inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.karyopharm.com/investor-relations